Claire Poll - Nov 21, 2021 Form 4 Insider Report for Verona Pharma plc (VRNA)

Role
General Counsel
Signature
/s/ Claire Poll
Stock symbol
VRNA
Transactions as of
Nov 21, 2021
Transactions value $
-$646,032
Form type
4
Date filed
12/27/2022, 05:50 PM
Previous filing
Nov 3, 2021
Next filing
Feb 3, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VRNA Ordinary Shares Gift $0 -90.1K -3.52% $0.00 2.47M Nov 21, 2021 Direct F1
transaction VRNA Ordinary Shares Gift $0 +90.1K +18.62% $0.00 574K Nov 21, 2021 By Trust F1, F2
transaction VRNA Ordinary Shares Gift $0 -90.1K -3.64% $0.00 2.38M Feb 22, 2022 Direct F1
transaction VRNA Ordinary Shares Gift $0 +90.1K +15.7% $0.00 664K Feb 22, 2022 By Trust F1, F2
transaction VRNA Ordinary Shares Gift $0 -90.1K -3.78% $0.00 2.29M May 22, 2022 Direct F1
transaction VRNA Ordinary Shares Gift $0 +90.1K +13.57% $0.00 754K May 22, 2022 By Trust F1, F2
transaction VRNA Ordinary Shares Gift $0 -90.1K -3.93% $0.00 2.2M Aug 21, 2022 Direct F1
transaction VRNA Ordinary Shares Gift $0 +90.1K +11.95% $0.00 844K Aug 21, 2022 By Trust F1, F2
transaction VRNA Ordinary Shares Gift $0 -170K -7.72% $0.00 2.03M Nov 22, 2022 Direct F1, F3
transaction VRNA Ordinary Shares Gift $0 +170K +20.14% $0.00 1.01M Nov 22, 2022 By Trust F1, F2
transaction VRNA Ordinary Shares Sale -$646K -240K -23.66% $2.69* 774K Dec 22, 2022 By Trust F1, F2, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reported securities are represented by American Depositary Shares ("ADSs") (unless otherwise indicated), each of which represents eight (8) Ordinary Shares of the Issuer.
F2 Held by a family trust of which (a) the Reporting Person and spouse are trustees and (b) the Reporting Person and members of her immediate family are the sole beneficiaries of the trust.
F3 Consists of (i) 1,990,000 Ordinary Shares underlying Restricted Share Units (each of which represents a contingent right to receive one (1) Ordinary Share of the Issuer) (which may be represented by 248,750 ADSs); (ii) 42,632 Ordinary Shares underlying 5,329 ADSs; and (iii) 7 Ordinary Shares.
F4 The price reported represents the weighted average sale price of the ADSs divided by eight (8). These shares were sold in multiple transactions at prices ranging from $2.675 to $2.7138, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.